Randomized Controlled Trial of Emergency Transjugular Intrahepatic Portosystemic Shunt Versus Emergency Portacaval Shunt Treatment of Acute Bleeding Esophageal Varices in Cirrhosis

Journal of Gastrointestinal Surgery

Volumn 16, Issue 11, 2012, Pages 2094-2111

  Orloff, Marshall J ^a   Vaida, Florin ^a   Haynes, Kevin S ^a   Hye, Robert J ^a   Isenberg, Jon I ^a   Jinich Brook, Horacio ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

Bleeding varices; Cirrhosis; Emergency shunt; TIPS

Indexed keywords

EID: 84869115652     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-2003-6     Document Type: Article

References (67)

1. Graham DY, Smith H. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809.
2. Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 1982; 82: 986-973.
3. Orloff MJ. Portal hypertension and portacaval shunt. In: Souba W, Wilmore D (eds). Surgical Research, San Diego, CA; Harcourt Brace, 2001, pp. 637-701.
4. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362: 823-832.
5. deFranchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768.
6. Boyer TD, Haskal ZJ. AASLD practice guideline. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400.
7. Boyer TD, Haskal ZJ. AASLD practice guideline update. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 57: 1-16.
8. García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mössner J, Bosch J, for the Early TIPS Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379.
9. Rosemurgy AS, Molloy DL, Thomerz DP, Villadolid DV, Cowgill SM, Zervos EE. TIPS in Florida: is its application a result of evidence-based medicine? J Am Coll Surg 2007; 204: 794-802.
10. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg 2009; 209: 25-40.
11. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Portal-systemic encephalopathy in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt treatment of acutely bleeding esophageal varices in cirrhosis. Ann Surg 2009; 250: 598-610.
12. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis-part 3. J Gastrointestinal Surg 2010; 14: 1782-1795.
13. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Direct costs of care in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt for bleeding esophageal varices in cirrhosis-part 4. J Gastrointest Surg 2010; 15: 38-47.
14. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplantation Proc 2010; 42: 4101-4108.
15. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Hepatocellular carcinoma in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. Am J Surg 2012; 203: 182-190.
16. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Alcoholic versus nonalcoholic cirrhosis in a randomized controlled trial of emergency therapy of bleeding varices. J Surg Research 2012; 174: 98-105.
17. Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Child-Turcotte score versus MELD for prognosis in a randomized controlled trial of emergency treatment of bleeding esophageal varices in cirrhosis. J Surg Research 2012. doi: 10. 1016/j. jss. 2012. 01. 004.
18. Orloff MJ. Emergency portacaval shunt: a comparative study of shunt, varix ligation and nonsurgical treatment of bleeding esophageal varices unselected patients with cirrhosis. Ann. Surg. 1967; 166: 456-478.
19. Orloff MJ, Bell RH Jr, Hyde PV, Skivolocki WP. Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann. Surg. 1980; 192: 325-340.
20. Orloff MJ, Orloff MS, Rambotti M, Girard B. Is portal-systemic shunt worthwhile in Child class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann. Surg. 1992; 216: 256-268.
21. Orloff MJ, Bell RH Jr, Orloff MS, Hardison WGM, Greenburg AG. Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices. Hepatology 1994; 20 (pt 1): 863-872.
22. Orloff MJ, Orloff MS, Orloff SL, Rambotti M. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995; 180: 257-272.
23. Moher D, Schulz KF, Altman D. The CONSORT statement revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Coll Surg 2001; 285: 1987-1991.
24. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
25. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ 2010; 340: c332.
26. Orloff MJ, Orloff SL, Orloff MS. Portacaval shunts: side-to-side and end-to-side. In: Atlas of upper gastrointestinal and hepato-pancreato-biliary surgery. P-A Clavien, MG Saar, Y Fong (eds). Springer, Berlin, 2007, pp. 687-702.
27. Conn HO, Liberthal MM. The hepatic coma syndromes and lactulose. Baltimore: Williams Wilkins; 1978.
28. Campbell DP, Parker DE, Anagnostopoulos CE. Survival prediction in portacaval shunt: a computerized statistical analysis. Am J Surg 1973; 126: 748-751.
29. Child III CG, Turcotte JG. Surgery and portal hypertension. In: The liver and portal hypertension. CG Child III, ed. Saunders, Philadelphia, pp. 1-85, 1964.
30. Khaitiyar JS, Luthra SK, Prasad N, et al. Transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt-a comparative study. Hepatogastroenterology 2000; 47: 492-497.
31. Helton WS, Maves R, Wicks K, et al. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001; 136: 17-20.
32. Rosemurgy AS, Bloomston M, Clark WC, et al. H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 2005; 241: 238-246.
33. Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB. Prosthetic H-graft portacaval shunts vs. transjugular intrahepatic portosystemic stent shunts: 18-year follow-up of a randomized trial. J AM Coll Surg 2012; 214: 445-455.
34. Henderson JM, Boyer TD, Kutner MH, et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 20006; 130: 1643-1651.
35. LeBerge JM. Transjugular intrahepatic portosystemic shunt-role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax. Clin Liver Dis 2006; 10: 583-598.
36. Kalva SP, Salazar GM, Walker TG. Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage. Tech Vasc Interventional Radiol 2009; 12: 92-101.
37. McCormick PA, Dick R, Panagou EB, et al. Emergency transjugular intrahepatic portosystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81: 1324-1327.
38. Jalan R, John TG, Redhead DN, et al. A comparative study of emergency transjugular intra-hepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroentreol 1993; 90: 1932-1937.
39. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996 111: 138-146.
40. Banares R, Casada M, Rodriguez-Láiz JM, et al. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998; 93: 75-79.
41. Gerbes AL, Golberg V, Waggershauser T, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Digest Dis Sci 1998; 43: 2463-2469.
42. Chau TN, Patch D, Chan YW, et al. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987.
43. Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590-597.
44. Tzeng W-S, Wu R-H, Lin C-Y, Chen J-J, Shen M-J, Koay L-B, Lee C. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of Apache II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol 2009; 10: 481-489.
45. Papatheodoridis GV, Goulis J, Leandre G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30: 612-622.
46. Luca A, Damico G, LaGalla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212: 411-421.
47. Escorseli A, Bañares R, García-Pagán JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002; 35: 385-392.
48. Afdhal NH, Curry MP. Early TIPS to improve survival in acute variceal bleeding. N Engl J Med 2010; 362: 2421-2422.
49. Clark W, Hernandez J, McKeon B, Villadolid D, Al-Saadi S, Mullinax J, Ross S, Rosemurgy II AS. Surgical shunting versus transjugular intrahepatic portosystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surgeon 2010; 76: 857-864.
50. Clark W, Golkar F, Luberice K, Toomey P, Paul H, Marcadis A, Okpaleke C, Vice M, Hernandez J, Alsina A, Rosemurgy AS. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts? Am J Surg 2011; 202: 561-564.
51. Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicenter study. Liver Int 2007; 27: 742-747.
52. Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 2005; 185: 472-480.
53. Barrio J, Ripoli C, Banares R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 2005; 55: 120-124.
54. Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Oi X, Bai M, Wu K, Fan D. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunts with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroentrol Hepatol 2010; 25: 1718-1725.
55. Amarapurkar D, Sanyal A. Improving survival in patients with decompensated cirrhosis. J Gastroenterol Hepatol 2010; 25: 1716-1717.
56. Korula J, Yelin A, Yamada S, et al. A prospective randomized controlled comparison of chronic endoscopic variceal sclerotherapy and portal systemic shunt for variceal hemorrhage in Child class A cirrhotics: a preliminary report. Gastroenterology 1987; 92: 1745.
57. Planas R, Boix J, Broggi M, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1991; 100: 1078-1086.
58. Isaksson B, Jeppsson B, Gengtsson F, et al. Mesocaval shunt or repeated sclerotherapy: effects on rebleeding and encephalopathy-a randomized trial. Surgery 1995; 117: 498-504.
59. Henderson JM, Kutner MH, Millikan WJ, et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis, a prospective randomized trial. Ann Intern Med 1990; 112: 262-269.
60. Rikkers LF, Burnett DA, Volentine GD, et al. Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg 1987; 206: 261-271.
61. Rikkers LF, Jin G, Burnett DA, et al. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1993; 165: 27-32.
62. Terés J, Bordas JM, Bravo D, et al. Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology 1987 7: 430-436.
63. Spina GP, Santambrogrio R, Opocher E, et al. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First state of a randomized, controlled trial. Ann Surg 1990; 211: 178-186.
64. Gralnek IM, Jensen DM, Kovacs TO, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999; 29: 44-50.
65. Villeneuve J-P, Pomier-Layrargues G, Duguay L, et al. Emergency portacaval shunt for variceal hemorrhage. A prospective study. Ann Surg 1987; 206: 48-52.
66. Soutter DI, Langer B, Taylor BR, Greig P. Emergency portosystemic shunting in cirrhotics with bleeding varices-a comparison of portacaval and mesocaval shunts. HPB Surg 1989; 1: 107-118.
67. Spina GP, Santambrogio R, Opocher E, et al. Emergency portosystemic shunt in patients with variceal bleeding. Surg Gynecol Obstet 1990; 171: 456-464.